Report Company Directory

HEMNET GROUP AB (PUBL)

• Hemnet Group AB "Penetration of higher tier packages is marginally down in..." by UBS AG
• Hemnet Group – Sell/SEK 249: June listings decrease 16% y/y by Nordea
• European Equity Strategy Observer by Santander
• European Equity Strategy Observer by Santander
• Hemnet Group AB "Cyclical risks near term, monetisation limitations medium..." by UBS AG
• Hemnet Group – Sell/SEK 249: Hemnet Max: Bidding premium data by Nordea
• Hemnet (Buy): Highest interest since IPO – FAQ & answers + Q2 preview by Carnegie Investment Bank AB (publ)
• Santander European Weekly Wrap, Friday, June 20, 2025 by Santander
• Still waiting for an inflection by BNP Paribas Exane
• Stoxx Europe 600 Screening: June 2025 by Santander

Hemogenyx Pharmaceuticals

• Hybridan Small Cap Feast - 30 October 2024 by Hybridan
• Hybridan Small Cap Feast - 02 Feb 24 by Hybridan
• Hemogenyx Pharmaceuticals: 1 director by SmartInsider

HEMOGENYX PHARMACEUTICALS PLC

• Hybridan Small Cap Feast: 24/02/2025 by Hybridan
• Small Cap Feast by Hybridan

Hemostemix

• Hemostemix Inc: 1 director by SmartInsider
• Teck is Interested in This Copper-Silver-Gold Junior by Fundamental Research
• Meta’s Latest Announcement Is Highly Promising by Fundamental Research
• Hemostemix Inc. (TSXV: HEM / OTC: HMTXF) – Awaiting Results of Phase II Trials of a Potential Therapy for Cardiovascular Diseases – Initiating Coverage by Fundamental Research
• Hemostemix Announces Grant of Stock Options by Newsfile Corp.
• Hemostemix Announces Closing of Unit Private Placement by Newsfile Corp.
• Hemostemix Announces Private Placement Update by Newsfile Corp.
• Hemostemix Announces Corporate Update by Newsfile Corp.
• Hemostemix Announces Closing of Existing Private Placement and Announces a New Private Placement by Newsfile Corp.
• Hemostemix Files Its Unaudited Condensed Consolidated Interim Financial Statements and Management Discussion and Analysis for the Three Months Ended March 31, 2020 by Newsfile Corp.

HEMP & HEALTH SPOLKA AKCYJNA